Sponsor Pipeline

Shanghai Guangsheng Biopharmaceutical Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07398339 Cosiporfin Sodium for Injection Photodynamic Therapy Biliary Tract Cancers (BTC) Recruiting
Disease Areas
Cholangiocarcinoma (1)
Get alerts when Shanghai Guangsheng Biopharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free